BÜHLMANN Laboratories AG
🇨🇭Switzerland
- Country
- 🇨🇭Switzerland
- Ownership
- -
- Established
- 1976-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.buhlmannlabs.ch/
Clinical Trials
3
Active:0
Completed:3
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)BÜHLMANN FPELA in the Diagnosis of Exocrine Pancreatic Insufficiency
Completed
- Conditions
- Exocrine Pancreatic Insufficiency
- First Posted Date
- 2020-09-16
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Bühlmann Laboratories AG
- Target Recruit Count
- 201
- Registration Number
- NCT04548778
- Locations
- 🇩🇪
Universitätsklinikum Halle (Saale), Halle (Saale), Germany
IBDoc® Canadian User Performance Evaluation
Not Applicable
Completed
- Conditions
- Inflammatory Bowel Diseases
- First Posted Date
- 2018-01-23
- Last Posted Date
- 2018-01-24
- Lead Sponsor
- Bühlmann Laboratories AG
- Target Recruit Count
- 61
- Registration Number
- NCT03408249
- Locations
- 🇨🇦
Division of Gastroenterology, Department of Medicine, Faculty of Medicine University of Alberta,, Edmonton, Alberta, Canada
🇨🇦GIRI (GI Research Institute), Vancouver, British Columbia, Canada
🇨🇦Hôtel-Dieu de Lévis,, Lévis, Quebec, Canada
BÜHLMANN fCAL™ ELISA - Aid in Differentiation of IBD From IBS
Completed
- Conditions
- Irritable Bowel SyndromeInflammatory Bowel Disease
- First Posted Date
- 2015-01-30
- Last Posted Date
- 2019-01-18
- Lead Sponsor
- Bühlmann Laboratories AG
- Target Recruit Count
- 478
- Registration Number
- NCT02351635
- Locations
- 🇺🇸
Stanford Center for Clinical & Translational Research & Education, Palo Alto, California, United States
🇺🇸Gastro Health, Miami, Florida, United States
🇺🇸Gastroenterology Assocaites of Central Georgia, Macon, Georgia, United States
News
No news found